StreetInsider.com News Articles

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced it has engaged AM Public Relations (AM PR), a healthcare-focused public relations agency specializing in media relations, thought leadership, and strategic communications for healthcare and technology companies.

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Mon, 13 Jul 2026 07:00:00 -0400

The engagement is intended to support NetraMark's broader communications strategy as the Company continues to advance its proprietary NetraAI platform and expand industry

NetraMark signs first CRO contract to analyze neurodegeneration data

Thu, 09 Jul 2026 07:00:22 -0400

NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) signed a contract to analyze phase 2 neurodegeneration clinical trial data through a contract research organization (CRO) partner, the Toronto-based company announced July 9, 2026.

The agreement marks the company's first contract flowing through a CRO rather than directly with a biopharmaceutical company. Under the deal, NetraMark will apply its NetraAI platform to identify what it calls Model-Derived Subgroups and treatment-response patterns within the neurodegenerative disease dataset.

"This contract is an important commercial milestone for NetraMark because it represents our first contract flowing through a CRO, rather than directly with a biopharmaceutical company," said George

NetraMark signs first CRO contract to analyze neurodegeneration data

Thu, 09 Jul 2026 07:00:22 -0400

"This contract is an important commercial milestone for NetraMark because it represents our first contract flowing through a CRO, rather than directly with a biopharmaceutical company," said George

NetraMark signs first CRO contract to analyze neurodegeneration data

Thu, 09 Jul 2026 07:00:22 -0400

"This contract is an important commercial milestone for NetraMark because it represents our first contract flowing through a CRO, rather than directly with a biopharmaceutical company," said George

NetraMark signs first CRO contract to analyze neurodegeneration data

Thu, 09 Jul 2026 07:00:22 -0400

"This contract is an important commercial milestone for NetraMark because it represents our first contract flowing through a CRO, rather than directly with a biopharmaceutical company," said George

NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner